During the past decade, Universitätsklinik Essen; Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinik Essen; Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie" #1 collaborator was "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Copenhagen HIV Programme (CHIP) -- Copenhagen, Denmark" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinik Essen; Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie" are "Basal Cell Carcinoma" (1 trials), "Follicular Lymphoma" (1 trials), "HIV Infection" (1 trials) and "HIV Infections" (1 trials). Many other conditions were trialed in "Universitätsklinik Essen; Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinik Essen; Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "All licensed antiretroviral medications" (1 trials), "Bendamustine" (1 trials), "Placebo" (1 trials), "Rituximab" (1 trials) and "Venetoclax" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinik Essen; Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinik Essen; Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Universitätsklinik Essen; Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinik Essen; Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".